ANIXA BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ANIXA BIOSCIENCES, INC. (ANIX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 11.28% for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-01-12
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 11.28%, a 189.23% increase from fiscal 2024.
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 3.90%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2025-10-31 | 11.28% 10-K · filed 2026-01-12 |
| 2024-10-31 | 3.90% 10-K · filed 2026-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |